¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-15
±³À°ÀÏÀÚ : 2022-04-15
±³À°Àå¼Ò : °æÁÖ ¶óÇÑ ¼¿·ºÆ® È£ÅÚ ÄÁº¥¼ÇȦ  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ(18.7 ¸íĪº¯°æ ´ëÇÑÈ­Çпä¹ýÇÐȸ)
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755  
À̸ÞÀÏ : ksc@ksac.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 140,000¿ø      
ºñ°í Á¤È¸¿ø Àü°øÀÇ 5¸¸¿ø,ÀüÀÓÀÇ 8¸¸¿ø,Àü¹®ÀÇ ¹× ÀÏ¹Ý 10¸¸¿ø ºñȸ¿ø Àü°øÀÇ 7¸¸¿ø,ÀüÀÓÀÇ 10¸¸¿ø, Àü¹®ÀÇ ¹× ÀÏ¹Ý 12¸¸¿ø ÇöÀåµî·Ï Àü°øÀÇ 9¸¸¿ø, ÀüÀÓÀÇ 12¸¸¿ø, Àü¹®ÀÇ ¹× ÀÏ¹Ý 14¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-15 ¾ÆÁ¦³ª+¸®°ÖȦ 07:30~08:00 CMV infection vs. CMV diseases - optimal prophylaxis & treatment  ÀÌ»ó¿À(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-15 ¾ÆÁ¦³ª+¸®°ÖȦ 08:00~08:30 Immune modulating agent - infection risk and prophylaxis  ¼­À¯ºó(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 08:30~09:20 Redefining Peace of Mind in HIV care  ÇãÁß¿¬(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 04-15 º£°¡È¦ 08:30~09:20 Therapeutic role of new ¥â-lactam/¥â-lactamase inhibitors in patient with MDR Gram-negative pathogens.  À±¿µ°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 09:20~09:50 Host-based PK/PD for antibiotic therapy: sepsis and immunocompromised hosts  À̵¿°Ç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 09:50~10:20 Antibiotic agent PK/PD: therapeutic drug monitoring for optimized antibiotic dosing  À̽Âȯ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 10:20~10:50 Antimicrobial synergism for multi-drug resistant Gram-negative bacterial infection  °­Ã¶ÀÎ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 11:10~11:40 Antimicrobial stewardship in Korea: current status and the way forward  ±èºÀ¿µ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 11:40~12:10 Korean core element of antimicrobial stewardship program: prerequisites for activation  ±Ç±âÅÂ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 13:00~13:50 The challenges of current diagnostic and treatment of IFI: The Value of CRESEMBA/VFEND/ERAXIS  ¾ÈÁø¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 16:00~16:30 Oral antivirals and monoclonal antibody for COVID-19  ¹Ú¿Ï¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 16:30~17:00 Clinical usefulness and optimal use of immune modulating agents in COVID-19  ÃÖÁØ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-15 ÄÁº¥¼ÇȦ 17:00~17:30 Antibiotic treatment for COVID-19 pneumonia: pros and cons  ÃßÀºÁÖ(¼øõÇâÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ & ACC(American College of Cardiology) Asia 2022 (¿Â,¿ÀÇÁ¶óÀÎ)(1ÀÏÂ÷) : 2022-04-15
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ)4¿ù15ÀÏ À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ(À½¼ºÁúȯ) : 2022-04-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
84 °æºÏ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ Á¦4Â÷ Áõ·ÊÅä·Ðȸ : 2018-08-21 0 385 2018-07-28
83 Ãæ³² ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 8¿ù ¿¬¼ö°­Á : 2018-08-21 0 359 2018-07-28
82 °­¿ø ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus conference(3Â÷: °­¿ø±Ç) : 2018-08-20 0 357 2018-07-28
81 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ ¾à¹°Ä¡·á ¿¬¼ö°­Á : 2018-08-19 0 412 2018-07-28
80 ¼­¿ï Á¦16ȸ ±è¾È°úº´¿ø ½ÉÆ÷Áö¾ö : 2018-08-19 1 738 2018-07-28
79 ¼­¿ï 2018 ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ °³¿ø¼¼¹Ì³ª : 2018-08-19 0 650 2018-07-28
78 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦7ȸ ¿°Áõ¼º ÀåÁúȯ ¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-08-19 0 263 2018-07-28
77 ±¤ÁÖ Á¦30Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2018-08-19 0 625 2018-07-28
76 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦ 3ȸ Current Concepts and Techniques In Knee Surgery (CCTIKS) -SMC Live Surgery & Symposium- : 2018-08-19 0 562 2018-07-28
75 ¼­¿ï 2018 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰú ¿¬¼ö°­Á : 2018-08-19 0 750 2018-07-28
74 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-19 0 858 2018-07-28
73 ´ë±¸ ´ëÇѳ»°úÇÐȸ Á¦18ȸ ³»°úÀü¹®ÀÇ Æò»ý±³À° ¿¬¼ö°­Á : 2018-08-19 0 461 2018-07-28
72 ¼­¿ï ´ëÇѼҾÆû¼Ò³âÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¼ºÀÎADHD¿¬±¸È¸ "¼ºÀÎ ADHD Áø·áÀÇ ½ÇÀü ±æ¶óÀâÀÌ" : 2018-08-19 0 822 2018-07-28
71 ¼­¿ï Á¦3ȸ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ ÃÊÀ½ÆÄ¿öÅ©¼¥ : 2018-08-19 0 565 2018-07-28
70 ¼­¿ï ´ëÇѺñ°úÇÐȸ RHINOLOGY UPDATE SYMPOSIUM IN 2018 : 2018-08-18 0 429 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷